Besremi costs $9,700+ per injection without insurance. Learn how to save with copay programs, patient assistance, and other strategies in 2026.
Let's be honest: Besremi (Ropeginterferon Alfa-2b-njft) is one of the most expensive medications most patients will ever encounter. At roughly $9,700 to $11,000 per injection without insurance — and injections every two weeks — the annual cost can exceed $250,000. That's a number that would make anyone's stomach drop.
But here's the good news: most patients do not pay anywhere near the full cash price. Between insurance coverage, manufacturer programs, and patient assistance, many patients pay $0 per month. This guide walks you through every option available in 2026 to reduce your Besremi costs.
Besremi is a specialty biologic medication with no generic or biosimilar alternative. Here are the current approximate costs:
These prices are based on average wholesale pricing and may vary slightly by pharmacy. Because Besremi is only available through specialty pharmacies, discount cards from sites like GoodRx or SingleCare typically do not apply — those services primarily cover medications at retail pharmacies.
The single best way to reduce your out-of-pocket costs for Besremi is through the PharmaEssentia SOURCE Copay Assistance Program.
If you have commercial insurance, this program should be your first stop. Many patients end up paying nothing out of pocket for their Besremi prescriptions after enrolling.
For patients who are uninsured or underinsured, PharmaEssentia offers a Patient Assistance Program that provides Besremi at no cost.
If you're uninsured and have been diagnosed with polycythemia vera, do not assume you can't afford treatment. This program exists specifically to help you.
Medicare patients are not eligible for the PharmaEssentia copay program, but there are other options:
Several independent foundations provide copay assistance for specialty medications. These change frequently based on funding, but organizations worth checking include:
Funding for these programs opens and closes throughout the year. If a program is currently closed, check back monthly or ask to be placed on a waitlist.
If you have Medicare Part D and limited income, you may qualify for Extra Help, which significantly reduces prescription copays and premiums. Contact Medicare at 1-800-MEDICARE (1-800-633-4227) or visit medicare.gov to check eligibility.
Besremi can be covered under either the medical benefit (administered in your doctor's office, billed as a medical service) or the pharmacy benefit (shipped from a specialty pharmacy). Depending on your insurance plan, one route may have a lower out-of-pocket cost than the other.
Ask your doctor's office and insurance company to compare costs under both benefits. In some cases, receiving Besremi as part of an office visit (buy-and-bill) results in lower patient responsibility.
If your insurance denies coverage for Besremi, don't give up. You have the right to appeal, and denials are often overturned. Your doctor can submit a letter of medical necessity citing:
PharmaEssentia SOURCE also provides appeals assistance and can help your doctor with the documentation.
Clinical trials for polycythemia vera treatments may provide access to medications at no cost. Rusfertide, a new hepcidin mimetic, is currently in Phase III trials and may be available through trial enrollment. Ask your hematologist about clinical trial options or search at ClinicalTrials.gov.
Traditional prescription discount cards (GoodRx, SingleCare, RxSaver, etc.) generally do not work for Besremi. These services primarily negotiate discounts at retail pharmacies, and Besremi is only available through specialty pharmacies with different pricing structures.
The PharmaEssentia copay program is more effective than any discount card for reducing your Besremi costs. If you have commercial insurance, it's the best option available.
As of 2026, there is no generic or biosimilar version of Besremi available. Because Besremi is a biologic (produced from living cells), a generic equivalent would need to be approved as a "biosimilar" through a lengthy FDA process. No biosimilar applications for Besremi have been filed.
If cost is a barrier and you cannot access financial assistance, talk to your doctor about alternative treatments for polycythemia vera. Hydroxyurea, the most common alternative, costs approximately $30 to $100 per month for the generic version.
The sticker price of Besremi is alarming, but the actual cost most patients pay is dramatically lower. The key is to take advantage of every program available before your first prescription arrives. Don't wait for a surprise bill — set up financial assistance at the same time your doctor writes the prescription.
If you need help finding Besremi in stock, visit Medfinder or check out our guide on how to find Besremi near you. And for a complete overview of the medication, read our article on what Besremi is and how it works.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
